Quênia - inglês - Pharmacy and Poisons Board

menarini international operations luxembourg s.a 1, avenue de la gare, l-1611 luxembourg - nebivolol (as nebivolol hydrochloride) and… - film-coated tablet - 5mg nebivolol (as nebivolol hydrochloride) and… - beta blocking agents: selective beta blocking

Quênia - inglês - Pharmacy and Poisons Board

menarini international operations luxembourg s.a 1, avenue de la gare, l-1611 luxembourg - nebivolol (as nebivolol hydrochloride) and… - film-coated tablet - 5mg nebivolol (as nebivolol hydrochloride) and… - beta blocking agents: selective beta blocking

União Europeia - inglês - EMA (European Medicines Agency)

menarini international operations luxembourg s.a. (miol) - febuxostat - gout - antigout preparations - 80 mg strength:treatment of chronic hyperuricaemia in conditions where urate deposition has already occurred (including a history, or presence of, tophus and/or gouty arthritis).adenuric is indicated in adults.120 mg strength:adenuric is indicated for the treatment of chronic hyperuricaemia in conditions where urate deposition has already occurred (including a history, or presence of, tophus and/or gouty arthritis).adenuric is indicated for the prevention and treatment of hyperuricaemia in adult patients undergoing chemotherapy for haematologic malignancies at intermediate to high risk of tumor lysis syndrome (tls).adenuric is indicated in adults.

União Europeia - inglês - EMA (European Medicines Agency)

menarini international operations luxembourg s.a. - pemetrexed disodium hemipentahydrate - carcinoma, non-small-cell lung; mesothelioma - antineoplastic agents - malignant pleural mesothelioma ciambra in combination with cisplatin is indicated for the treatment of chemotherapy naïve patients with unresectable malignant pleural mesothelioma. non-small cell lung cancer ciambra in combination with cisplatin is indicated for the first line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology. ciambra is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy. ciambra is indicated as monotherapy for the second line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology.,

Reino Unido - inglês - MHRA (Medicines & Healthcare Products Regulatory Agency)

a. menarini farmaceutica internazionale srl - ranolazine - modified-release tablet - 500mg

Reino Unido - inglês - MHRA (Medicines & Healthcare Products Regulatory Agency)

a. menarini farmaceutica internazionale srl - ranolazine - modified-release tablet - 375mg

Reino Unido - inglês - MHRA (Medicines & Healthcare Products Regulatory Agency)

a. menarini farmaceutica internazionale srl - ranolazine - modified-release tablet - 750mg

União Europeia - inglês - EMA (European Medicines Agency)

menarini international operations luxembourg s.a. - oritavancin (diphosphate) - soft tissue infections; skin diseases, bacterial - antibacterials for systemic use, - tenkasi is indicated for the treatment of acute bacterial skin and skin structure infections (absssi) in adults and paediatric patients aged 3 months and older (see sections 4.2, 4.4 and 5.1).consideration should be given to official guidance on the appropriate use of antibacterial agents.

União Europeia - inglês - EMA (European Medicines Agency)

menarini international operations luxembourg s.a. - meropenem trihydrate, vaborbactam - urinary tract infections; bacteremia; bacterial infections; respiratory tract infections; pneumonia; pneumonia, ventilator-associated - antibacterials for systemic use, - vaborem is indicated for the treatment of the following infections in adults:complicated urinary tract infection (cuti), including pyelonephritiscomplicated intra-abdominal infection (ciai)hospital-acquired pneumonia (hap), including ventilator associated pneumonia (vap).treatment of patients with bacteraemia that occurs in association with, or is suspected to be associated with, any of the infections listed above.vaborem is also indicated for the treatment of infections due to aerobic gram-negative organisms in adults with limited treatment options.consideration should be given to official guidance on the appropriate use of antibacterial agents.

União Europeia - inglês - EMA (European Medicines Agency)

a. menarini industrie farmaceutiche riunite s.r.l. - delafloxacin meglumine - community-acquired infections - antibacterials for systemic use, - quofenix is indicated for the treatment of the following infections in adults:acute bacterial skin and skin structure infections (absssi),community-acquired pneumonia (cap), when it is considered inappropriate to use other antibacterial agents that are commonly recommended for the initial treatment of these infections (see sections 4.4 and 5.1).consideration should be given to official guidance on the appropriate use of antibacterial agents.